Results are incomplete because these sources exceeded their search time limit: Current NDC. Try a more specific name or an exact identifier.
21 matching records for Response Kit.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of the mRNA expression of multiple genes associated with a response to (suspected) infection, in a clinical specimen, using a nucle...
A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple cell-mediated (i.e., non-immunoglobulin) host immune response markers of bacterial and/or viral infection in a c...
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of non-specific reagin antibodies that are produced in response to infection with Treponema pallidum bacteria, in a clinical specim...
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of heterophile antibodies produced in response to Epstein-Barr virus (EBV) in a clinical specimen, using an agglutination method. T...
A collection of reagents and other associated materials intended for the qualitative and/or quantitative detection of mRNA expression and/or determination of the gene mutation status of multiple genes associated with cancer in a clinical specimen, using a n...
A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of heterophile antibodies produced in response to Epstein-Barr virus (EBV) in a clinical specimen within a short period, rel...
A collection of reagents and other associated materials intended to be used for the qualitative and/or semi-quantitative detection of heterophile antibodies produced in response to Epstein-Barr virus (EBV) in a clinical specimen within a short period, relat...
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of reactive T-cells in a clinical specimen which have become activated in response to stimulation by one or multiple specific antig...
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of antibodies to a programmed death-ligand 1 (PD-L1) inhibitor (e.g., atezolizumab, avelumab, durvalumab), [also known as anti-drug...
A collection of reagents and other associated materials intended to be used to evaluate a clinical specimen to diagnose, monitor or predict colorectal cancer, and/or select treatment options and/or monitor the response to cancer therapy, based on multiple d...
A collection of reagents and other associated materials intended to be used for the qualitative detection of the KRAS (v-ki-ras2 kirsten rat sarcoma viral oncogene homolog) mutation status and/or to evaluate a clinical specimen to predict or monitor the res...
A collection of reagents and other associated materials intended to be used to evaluate a clinical specimen to predict or monitor the response to treatment with epidermal growth factor receptor (EGFR) inhibitors by determining the EGFR mutation status or mR...
A collection of reagents and other associated materials intended to be used for the quantitative detection of alpha-2-antiplasmin in a clinical specimen, using a chromogenic method. It is typically used in the diagnosis of congenital bleeding disorders or d...
A collection of reagents and other associated materials intended to be used for the quantitative detection of alpha-2-antiplasmin in a clinical specimen, using an enzyme immunoassay (EIA) method. It is typically used in the diagnosis of congenital bleeding ...
A collection of reagents and other associated materials intended to be used to select treatment options and/or monitor the response to cancer therapy by determining the mutation status of multiple regions of the BRAF (v-raf murine sarcoma viral oncogene hom...
A collection of reagents and other associated materials intended to be used to select treatment options and/or monitor the response to cancer therapy by determining the V600 mutation status of the BRAF (v-raf murine sarcoma viral oncogene homolog B1) gene e...
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of circulating tumour DNA (ctDNA) and/or RNA (ctRNA) in a clinical specimen, using a nucleic acid technique (NAT). ctDNA and ctRNA ...
A collection of reagents and other associated materials intended to be used to help select cancer treatment options and/or monitor the response to cancer therapy by determining the mutation status of the fibroblast growth factor receptor (FGFR) gene, using ...
A collection of reagents and other associated materials intended to be used to diagnose, monitor or predict the enhancer of zeste homolog 2 (EZH2) gene mutation status of a tumour tissue specimen, using a nucleic acid technique (NAT). This test is intended ...
Collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of NTRK (e.g., NTRK1, NTRK2, and/or NTRK3) gene mutations and/or to evaluate a clinical specimen to predict or monitor the response t...
A collection of reagents and other associated materials intended to be used for the quantitative measurement of thymidine kinase in a clinical specimen, using an enzyme immunoassay (EIA) method. It is typically used as a prognostic marker to monitor the pro...